Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Cell Type	Stimulation
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	351292	Peak area	PAK	TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	417731	Peak area	PAK	IFN-G
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	440496	Peak area	PAK	TNF-alpha
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	444917	Peak area	HAHA	IFN-G
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	446161	Peak area	PAK	Untreated
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	456989	Peak area	PAK	IL-17A
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	470531	Peak area	BS4	IFN-G
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	507551	Peak area	HAHA	TNF-alpha
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	516405	Peak area	BS4	TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	529042	Peak area	BS4	TNF-alpha
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	534970	Peak area	BS4	Untreated
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	539312	Peak area	BS4	IL-17A
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	619137	Peak area	HAHA	IL-17A
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-	666519	Peak area	HAHA	Untreated
Reversed phase NEGATIVE ION MODE	TYROSINE (CAS# 60-18-4); (M-H)-		Peak area	HAHA	TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	2017902	Peak area	HAHA	IFN-G
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	2130782	Peak area	PAK	Untreated
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	2462272	Peak area	PAK	IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	2599783	Peak area	HAHA	Untreated
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	2654950	Peak area	HAHA	IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	2884900	Peak area	HAHA	TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	3126848	Peak area	BS4	TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	3358085	Peak area	BS4	TNF-alpha
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	3454380	Peak area	PAK	TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	3902920	Peak area	BS4	IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	3957850	Peak area	HAHA	TNF-alpha
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	4313037	Peak area	PAK	TNF-alpha
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	5063829	Peak area	PAK	IFN-G
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	5126022	Peak area	BS4	Untreated
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+H)+	6002115	Peak area	BS4	IFN-G
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+	22165	Peak area	PAK	IFN-G
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+	22464	Peak area	HAHA	Untreated
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	BS4	IFN-G
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	BS4	IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	BS4	TNF-alpha
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	BS4	TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	BS4	Untreated
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	HAHA	IFN-G
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	HAHA	IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	HAHA	TNF-alpha
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	HAHA	TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	PAK	IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	PAK	TNF-alpha
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	PAK	TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE	TYROSINE (CAS# 60-18-4); (M+NA)+		Peak area	PAK	Untreated